HNSN Hansen Medical, Inc. (MM)

Glancy Binkow & Goldberg LLP, a law firm with significant experience in prosecuting class actions, and substantial expertise in actions involving corporate fraud, has been appointed as Lead Counsel in the consolidated securities class action against Hansen Medical, Inc. ("Hansen" or the "Company") (Nasdaq:HNSN), and certain of the Company's executive officers, currently pending in the United States District Court for the Northern District of California -- Curry v. Hansen Medical, Inc., et al., Lead Case No. 5:09‑cv‑05094‑JF.

If you wish to discuss this action or have any questions concerning this case or your rights or interests with respect to these matters, please contact Michael Goldberg, Esquire, of Glancy Binkow & Goldberg LLP, 1801 Avenue of the Stars, Suite 311, Los Angeles, California 90067, by telephone at (310) 201‑9150 or Toll Free at (888) 773‑9224, or by e‑mail to shareholders@glancylaw.com.

The complaint alleges that the defendants knew or recklessly disregarded that their public statements concerning Hansen's business, operations and prospects were materially false and misleading. Specifically, the complaint alleges that the defendants made false and/or misleading statements and/or failed to disclose: (1) that the Company had improperly recognized revenue; (2) that, as a result, the Company's revenue and financial results were overstated; (3) that the Company's financial results were not prepared in accordance with Generally Accepted Accounting Principles; (4) that the Company lacked adequate internal and financial controls; and (5) that, as a result of the above, the Company's financial statements were materially false and misleading at all relevant times.

On October 19, 2009, Hansen shocked investors when it revealed that the audit committee of Hansen's board of directors, upon the recommendation of management, concluded that the Company's previously issued financial statements contained in its annual report on Form 10‑K for the year ended December 31, 2008, and the Company's quarterly reports on Form 10‑Q for the quarters ended March 31, 2008, June 30, 2008, September 30, 2008, March 31, 2009 and June 30, 2009, should no longer be relied upon because of errors arising from "potential irregularities outside of the accounting department."  

If you purchased Hansen stock, if you have any questions or comments concerning this case, this announcement, or your rights or interests with respect to these matters, or if you would like an update concerning the status of this case, would like to learn more about the case, or if you have information and wish to discuss these matters further, please contact Michael Goldberg, Esquire, of Glancy Binkow & Goldberg LLP, 1801 Avenue of the Stars, Suite 311, Los Angeles, California 90067, by telephone at (310) 201‑9150 or Toll Free at (888) 773‑9224, by e‑mail to shareholders@glancylaw.com, or visit our website at http://www.glancylaw.com.

CONTACT: Glancy Binkow & Goldberg LLP, Los Angeles, CA

Michael Goldberg

(310) 201-9150

(888) 773-9224

shareholders@glancylaw.com

www.glancylaw.com